These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 22576890)

  • 1. Corrigendum: Infratentorial superficial siderosis: report of six cases and review of the literature.
    Deng L; Lin Y; Lin Y; Huang W
    Front Neurosci; 2024; 18():1388356. PubMed ID: 38516312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of superficial siderosis with iron chelation therapy.
    Cummins G; Crundwell G; Baguley D; Lennox G
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23843408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatable cerebellar ataxias.
    K P D; Kishore A
    Clin Park Relat Disord; 2020; 3():100053. PubMed ID: 34316636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Response of Deferiprone in Infratentorial Superficial Siderosis: a Systematic Review.
    Flores Martin A; Shanmugarajah P; Hoggard N; Hadjivassiliou M
    Cerebellum; 2021 Jun; 20(3):454-461. PubMed ID: 33409768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Treatment of Cerebellar Disorders.
    Mitoma H; Manto M; Gandini J
    Brain Sci; 2019 Dec; 10(1):. PubMed ID: 31878024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Superficial siderosis of the central nervous system caused by myxopapillary ependymoma of conus medullaris and cauda equine: a case report and literature review].
    Xu L; Hu MJ; Li YY; Qu HD; Qian WD; Liu XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):769-774. PubMed ID: 31420638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study.
    Cossu G; Abbruzzese G; Forni GL; Matta G; Pinto V; Ruffinengo U; Oppo V; Marchese R
    Neurol Sci; 2019 Jul; 40(7):1357-1361. PubMed ID: 30903420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year observational study of deferiprone in superficial siderosis.
    Kessler RA; Li X; Schwartz K; Huang H; Mealy MA; Levy M
    CNS Neurosci Ther; 2018 Mar; 24(3):187-192. PubMed ID: 29285884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deferiprone Reduces Hemosiderin Deposition in Superficial Siderosis.
    Kuo PH; Kuo SH; Lo RY
    Can J Neurol Sci; 2017 Mar; 44(2):219-220. PubMed ID: 27788692
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron chelation and multiple sclerosis.
    Weigel KJ; Lynch SG; LeVine SM
    ASN Neuro; 2014 Jan; 6(1):e00136. PubMed ID: 24397846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agranulocytosis with deferiprone treatment of superficial siderosis.
    Huprikar N; Gossweiler M; Callaghan M; Bunge P
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23925681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Superficial siderosis accompanied with massive degeneration of cerebellar vermis].
    Tajima Y; Mito Y
    No To Shinkei; 1999 Nov; 51(11):992-3. PubMed ID: 10586418
    [No Abstract]   [Full Text] [Related]  

  • 13. Pilot safety trial of deferiprone in 10 subjects with superficial siderosis.
    Levy M; Llinas R
    Stroke; 2012 Jan; 43(1):120-4. PubMed ID: 22034002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial siderosis of central nervous system with unknown cause: report of 2 cases and review of the literature.
    Chen H; Raza HK; Jing J; Ye X; Zhang Z; Hua F; Cui G
    Br J Neurosurg; 2019 Jun; 33(3):305-308. PubMed ID: 29160113
    [No Abstract]   [Full Text] [Related]  

  • 15. Superficial siderosis: a case report and review of the literature.
    Levy M; Turtzo C; Llinas RH
    Nat Clin Pract Neurol; 2007 Jan; 3(1):54-8; quiz 59. PubMed ID: 17205075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on a patient with superficial siderosis on deferiprone.
    Levy M; Llinas RH
    AJNR Am J Neuroradiol; 2012 Jun; 33(6):E99-100. PubMed ID: 22576890
    [No Abstract]   [Full Text] [Related]  

  • 17. Deferiprone reduces hemosiderin deposits in the brain of a patient with superficial siderosis.
    Levy M; Llinas RH
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):E1-2. PubMed ID: 21051507
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.